Table 2.
Group I (n = 153) | Group II (n = 150) | T test | P value | |
---|---|---|---|---|
Days from index PCI to the first day of Ramadan | ||||
Range | 65 – 170 | 62 – 265 | 0.411 | 0.522 |
Mean ± SD | 170.07 ± 64.21 | 165.43 ± 61.47 |
Group I | Group II | X2 | P value | |
---|---|---|---|---|
P2Y12 Inhibitor | ||||
Clopidogrel | ||||
N | 97 | 101 | 0.518 | 0.472 |
% | 63.4% | 67.3% | ||
Ticagrelor | ||||
N | 56 | 49 | ||
% | 36.6% | 32.7% | ||
Indication for PCI | ||||
ACS | ||||
N | 19 | 18 | 0.012 | 0.911 |
% | 12.4% | 12.0% | ||
Elective | ||||
N | 134 | 132 | ||
% | 87.6% | 88.0% | ||
MACEs | ||||
Yes | ||||
N | 23 | 8 | 7.759 | 0.005* |
% | 15.0% | 5.3% | ||
No | ||||
N | 130 | 142 | ||
% | 85.0% | 94.7% |
SD Standard Deviation, PCI Percutaneous coronary intervention, ACS Acute Coronary Syndrome, MACEs Major Adverse Cardiac Events
*Significant P value